rediff.com
e.g. Tata motors, Reliance MF, 500570
BSE | NSE

Natco Pharma Ltd.

524816 NATCOPHARM Group (A)

01 Jan,15:47
1398.70
11.40 (0.82%)
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Add to Watchlist
 
Day
Wk
Mn
6Mn
Yr
Volume Prev close Day's H/L (Rs.) 52wk H/L (Rs.) Mkt Cap (Rs. Cr)

Natco Pharma Ltd.

BUYSELL

22,724 1,387.30 1,404.95 - 1,384.00 1,638.35 - 804.70 25,050.72

News for Natco Pharma Ltd.

Natco Pharma Q2 Profit Surges 83% to Rs 676 Cr
Natco Pharma's net profit soared 83% YoY to Rs 676 crore in Q2 FY25, driven by strong sales growth. Revenue also increased significantly, with exports and domestic businesses performing well.
Nov 12, 2024 17:18
Mylan Settles...
Mylan Settles Patent Suit with Novo Nordisk over Generic Ozempic
Mylan Pharmaceuticals Inc. and Novo Nordisk have reached a settlement in the US over a patent infringement lawsuit regarding generic Ozempic, a drug used for blood sugar and weight loss.
Oct 07, 2024 10:46
Natco Pharma...
Natco Pharma Invests USD 8 Million in eGenesis for Xenotransplantation
Natco Pharma's Canadian arm invests USD 8 million in eGenesis, a biotech company focused on developing human-compatible organs for transplant. The investment will support research and bring...
Sep 04, 2024 15:44
Natco Pharma...
Natco Pharma Files Generic Cancer Drug Application with USFDA - Business News
Natco Pharma has submitted an ANDA to the USFDA for a generic version of Novartis' Tabrecta, a cancer drug. The company expects to be eligible for 180 days of marketing exclusivity.
Aug 29, 2024 17:10
Natco Pharma Q1 Profit Jumps 59% to Rs 668 Cr
Natco Pharma's consolidated net profit surged 59% to Rs 668 crore in Q1 FY24, driven by strong revenue growth. The company also declared an interim dividend of Rs 3 per share.
Aug 12, 2024 17:29

More News for Natco Pharma Ltd. »

(Rs. Crore)

Financial Results of Natco Pharma Ltd.

Mar ' 24Mar ' 23Mar ' 22Mar ' 21Mar ' 20
Sales3,568.902,351.001,767.801,653.501,790.20
Operating profit1,637.00844.70213.00417.60578.00
Interest14.508.6013.3011.3020.60
Gross profit1,727.20921.60294.30507.40681.20
EPS (Rs)72.9934.917.6216.9626.07

See more in Research Center »

About Natco Pharma Ltd.

Natco Pharma is an Indian multinational pharmaceutical company based in Hyderabad. The company manufactures finished dosage formulations active pharmaceutical ingredients and Agro chemical products. It is a major producer of branded oncology medicines cardiology, diabetology and other pharma specialty drugs. The company specialises in producing complex medicines at affordable prices. NATCO is a science driven company and focuses on limited competition molecules in the US. Wikipedia

News for Pharmaceuticals and health care

India to Expand...
India to Expand Food Testing Infrastructure for Exports
India's Export Inspection Council (EIC) is expanding food testing infrastructure to boost exports. The EIC is also implementing advanced technologies like IoT-based sampling techniques to...
Jan 01, 2025 21:33
Standard Glass...
Standard Glass IPO: Price Band at Rs 133-140, Opens Jan 6
Standard Glass Lining Technology's IPO opens on January 6 with a price band of Rs 133-140 per share, aiming to raise Rs 410.05 crore. The IPO includes a fresh issue and an offer for sale by...
Jan 01, 2025 21:25
Honda Cars India...
Honda Cars India Sales Surge 20% in 2024 - 1,31,871 Units
Honda Cars India reported a 20% sales growth in 2024, reaching 1,31,871 units. Domestic sales declined, while exports doubled, driven by the Honda Elevate SUV.
Jan 01, 2025 20:05
Telcos' Revenue...
Telcos' Revenue Up 10.5% in Q3, Govt Collection Rises 13%
Indian telcos saw a 10.5% rise in gross revenue in Q3 2024, driven by tariff hikes. Government revenue from telecom increased by 13%.
Jan 01, 2025 19:49
Nesco Ex-Director...
Nesco Ex-Director Settles Sebi Case for Rs 21.45 Lakh
Manu M Parpia, former independent director of Nesco Ltd, settled a Sebi case alleging violation of disclosure and regulatory norms by paying Rs 21.45 lakh.
Jan 01, 2025 19:48

More News »

Top News

India to Expand...
India to Expand Food Testing Infrastructure for Exports
India's Export Inspection Council (EIC) is expanding food testing infrastructure to boost exports. The EIC is also implementing advanced technologies like IoT-based sampling techniques to...
Jan 01, 2025 21:33
Standard Glass...
Standard Glass IPO: Price Band at Rs 133-140, Opens Jan 6
Standard Glass Lining Technology's IPO opens on January 6 with a price band of Rs 133-140 per share, aiming to raise Rs 410.05 crore. The IPO includes a fresh issue and an offer for sale by...
Jan 01, 2025 21:25
Bhuvnesh Kumar Appointed UIDAI CEO
Bhuvnesh Kumar, an IAS officer, has assumed charge as the new CEO of UIDAI, replacing Amit Agrawal. Kumar has a background in MeitY and held various positions in Uttar Pradesh.
Jan 01, 2025 20:45
Amit Shah Pushes Organic Farming: Quality Control, Fair Pricing Key
Amit Shah directs National Cooperative Organic Ltd (NCOL) to strengthen quality control and ensure fair pricing for organic produce, aiming to boost organic farming nationwide.
Jan 01, 2025 20:26
Honda Cars India...
Honda Cars India Sales Surge 20% in 2024 - 1,31,871 Units
Honda Cars India reported a 20% sales growth in 2024, reaching 1,31,871 units. Domestic sales declined, while exports doubled, driven by the Honda Elevate SUV.
Jan 01, 2025 20:05

More Top News »

Report Card

PE Ratios
19.16
EPS (Rs.)
72.99
Sales (Rs. Cr)
1,292.60
Face Value (Rs.)
2
Net Profit Margin (%)
36.61
Last Bonus
Last Dividend(%)
75
Return on Average Equity
23.36

BSE Announcements from Natco Pharma Ltd. (See all)

announcement Closure of Trading Window - 3 day(s) ago
announcement Sustainability Report For The Year 2023-2024 - 09 Dec 2024

Compare 'Natco Pharma Ltd.' with other stocks

  • Sun Pharmaceutical Industries Ltd.
  • 1,884.50
  • Compare
  • Divi's Laboratories Ltd.
  • 6,099.75
  • Compare
  • Dr. Reddy's Laboratories Ltd.
  • 1,388.25
  • Compare
  • Torrent Pharmaceuticals Ltd.
  • 3,359.95
  • Compare
  • Max Healthcare Institute Ltd.
  • 1,128.60
  • Compare
  • Apollo Hospitals Enterprise Ltd.
  • 7,294.20
  • Compare
  • Zydus Lifesciences Ltd.
  • 971.45
  • Compare
  • Aurobindo Pharma Ltd.
  • 1,334.40
  • Compare

Most Active

  • Change (Rs.)
  •  

Natco Pharma Ltd. performance snapshot

If you had invested Rs.  in Natco Pharma Ltd.,     ago

You would have  Rs. 1,026.72 

Add to Portfolio

Peers

  • LTP
  • Change (Rs.)
  • Change %
  • Mkt Cap (Rs. Cr)
  • Volume
Close
Add Natco Pharma Ltd. to your Portfolio
 
 
BSE NSE  
 
Close
Add Natco Pharma Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close